Gilmore Neil O'neill
CEO at Editas Medicine, Inc. (EDIT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $80K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 4SEC | EDITEditas Medicine, Inc. | Sell Plan | 5,124243,189 held (−2%) | $3.04 | $16K | -22.7% |
| Jun 5SEC | EDITEditas Medicine, Inc. | Sell Plan | 15,380248,313 held (−6%) | $2.70 | $42K | -13.0% |
| Mar 4SEC | EDITEditas Medicine, Inc. | Sell Plan | 5,394263,693 held (−2%) | $2.02 | $11K | +16.3% |
| Dec 4SEC | EDITEditas Medicine, Inc. | Sell Plan | 5,603269,087 held (−2%) | $2.15 | $12K | +9.3% |
- Sell
CEO Gilmore Neil O'neill sold $16K of EDIT at $3.04 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Gilmore Neil O'neill sold $42K of EDIT at $2.70 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Gilmore Neil O'neill sold $11K of EDIT at $2.02 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Gilmore Neil O'neill sold $12K of EDIT at $2.15 — pre-scheduled 10b5-1 plan sale.